Compared with the control group, we found a significant downregulation of the two hub genes (ERN1 and SLC11A1) in the NAFLD group, suggesting that their reduced expression may serve as potential risk factors for NAFLD. The gene discussed is SLC11A1; the disease is metabolic dysfunction-associated steatotic liver disease.